Immucell Corp
Animal health biologics company developing, manufacturing and commercializing products that improve the health and productivity of neonatal dairy and beef calves, including the First Defense product line
Granted 25.0K
Bought 3.3K
Bought 14.0K
Granted 3.5K
Bought 1.0K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Brigham Michael FDirector · 2 transactions | +12.2% | 229.8K | 25.0K | — | — |
| Tomsche David ScottDirector · 9 transactions | — | 131.4K | — | 3.3K | — |
| te Boekhorst Paul Francis OlivierPresident and CEO, Director · 3 transactions | — | 17.8K | — | 14.0K | — |
| Basse Gloria FDirector · 1 transaction | — | 3.5Kas of Jun 2025 | 3.5K | — | — |
| Gathagan Bryan K.Director · 1 transaction | — | 1.0Kas of Jun 2025 | — | 1.0K | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 3 years: +18.3K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.